1. Home
  2. AURA vs AUDC Comparison

AURA vs AUDC Comparison

Compare AURA & AUDC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AURA
  • AUDC
  • Stock Information
  • Founded
  • AURA 2007
  • AUDC 1992
  • Country
  • AURA United States
  • AUDC Israel
  • Employees
  • AURA N/A
  • AUDC N/A
  • Industry
  • AURA Biotechnology: Pharmaceutical Preparations
  • AUDC Telecommunications Equipment
  • Sector
  • AURA Health Care
  • AUDC Utilities
  • Exchange
  • AURA Nasdaq
  • AUDC Nasdaq
  • Market Cap
  • AURA 398.1M
  • AUDC 339.7M
  • IPO Year
  • AURA 2021
  • AUDC 1999
  • Fundamental
  • Price
  • AURA $7.51
  • AUDC $11.40
  • Analyst Decision
  • AURA Strong Buy
  • AUDC Buy
  • Analyst Count
  • AURA 4
  • AUDC 2
  • Target Price
  • AURA $23.00
  • AUDC $11.25
  • AVG Volume (30 Days)
  • AURA 139.9K
  • AUDC 124.9K
  • Earning Date
  • AURA 03-26-2025
  • AUDC 02-04-2025
  • Dividend Yield
  • AURA N/A
  • AUDC 1.56%
  • EPS Growth
  • AURA N/A
  • AUDC 78.82
  • EPS
  • AURA N/A
  • AUDC 0.50
  • Revenue
  • AURA N/A
  • AUDC $242,176,000.00
  • Revenue This Year
  • AURA N/A
  • AUDC $5.02
  • Revenue Next Year
  • AURA N/A
  • AUDC $4.31
  • P/E Ratio
  • AURA N/A
  • AUDC $23.14
  • Revenue Growth
  • AURA N/A
  • AUDC N/A
  • 52 Week Low
  • AURA $6.63
  • AUDC $7.70
  • 52 Week High
  • AURA $12.38
  • AUDC $14.04
  • Technical
  • Relative Strength Index (RSI)
  • AURA 38.25
  • AUDC 54.19
  • Support Level
  • AURA $7.50
  • AUDC $11.01
  • Resistance Level
  • AURA $8.16
  • AUDC $12.72
  • Average True Range (ATR)
  • AURA 0.31
  • AUDC 0.52
  • MACD
  • AURA -0.02
  • AUDC -0.07
  • Stochastic Oscillator
  • AURA 1.30
  • AUDC 52.86

About AURA Aura Biosciences Inc.

Aura Biosciences Inc is a clinical-stage biotechnology company developing precision immunotherapies to treat a range of solid tumors designed to preserve the function of organs afflicted with cancer. Its lead candidate bel-sar is in late-stage clinical development for the treatment of patients with primary choroidal melanoma, and other ocular oncology indications as well as in early-stage clinical development in bladder cancer. The Company views its operations and manages its business in one operating segment operating exclusively in the United States.

About AUDC AudioCodes Ltd.

AudioCodes Ltd develops and sells advanced and converged voice over IP and data networking solutions, products and applications to service providers and channels, OEMs, network equipment providers and system integrators. Its products include IP phones, session border controllers, voice applications, multi-service business routers, digital and analog media gateways, among others. The company generates revenues from the sale of products through a direct sales force and sales representatives. Its geographic segments are Israel, Americas, Europe, and the Far East. It derives a majority of the revenues from Americas segment.

Share on Social Networks: